Comment
doi: 10.1136/bmj.39254.924641.1F.
Gadolinium contrast may be risky in kidney disease
- PMID: 17599982
- PMCID: PMC1906672
- DOI: 10.1136/bmj.39254.924641.1F
Item in Clipboard
Comment
Gadolinium contrast may be risky in kidney disease
BMJ.
.
No abstract available
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review.BMJ. 2007 Jun 16;334(7606):1257. doi: 10.1136/bmj.39217.473275.55. Epub 2007 Jun 4. BMJ. 2007. PMID: 17548364 Free PMC article.
-
Diagnosis of peripheral arterial disease of the lower limb.BMJ. 2007 Jun 16;334(7606):1229-30. doi: 10.1136/bmj.39244.344664.80. BMJ. 2007. PMID: 17569893 Free PMC article.
Similar articles
-
How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?Clin J Am Soc Nephrol. 2008 May;3(3):649-51. doi: 10.2215/CJN.00670208. Epub 2008 Apr 2. Clin J Am Soc Nephrol. 2008. PMID: 18385396 No abstract available.
-
[Gadolinium: a true problem for the nephrologists?].G Ital Nefrol. 2008 Jan-Feb;25(1):3-4. G Ital Nefrol. 2008. PMID: 18264906 Italian. No abstract available.
-
MRI contrast agents may pose risk for patients with kidney disease.JAMA. 2007 Jan 17;297(3):252-3. doi: 10.1001/jama.297.3.252. JAMA. 2007. PMID: 17227968 No abstract available.
-
[Nephrogenic systemic fibrosis].G Ital Nefrol. 2008 Jan-Feb;25(1):14-20. G Ital Nefrol. 2008. PMID: 18264914 Review. Italian.
-
Gadolinium-Induced Fibrosis.Annu Rev Med. 2016;67:273-91. doi: 10.1146/annurev-med-063014-124936. Annu Rev Med. 2016. PMID: 26768242 Review.
References
-
- Collins R, Burch J, Aguiar-Ibanez R, Craig D, Wright K, et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ 2007;334:1257-61. (16 June.) - PMC - PubMed
-
- Grobner T, Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-8. - PubMed
-
- Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced magnetic resonance imaging and nephrogenic systemic fibrosis—a retrospective study of a renal replacement therapy cohort. Radiology (in press). - PubMed
-
- Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol 2007;188:586-92. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
